NCT04778527View on ClinicalTrials.gov

A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

NAActive, not recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
HIV Infections
Interventions
DRUG

Dual Prevention Pill

a single over-encapsulated DPP containing a PrEP tablet and a COC

DRUG

PrEP tablet and a COC as two separate tablets

PrEP tablet and a COC as two separate tablets

Trial Locations (1)

2001

Witwatersrand Reproductive Health & HIV Institute's (WITS RHI), Johannesburg

All Listed Sponsors
lead

Population Council

OTHER